primari
biliari
cirrhosi
pbc
chronic
autoimmun
liver
diseas
character
inflamm
destruct
intrahepat
biliari
epitheli
cell
ultim
lead
liver
failur
serolog
hallmark
pbc
presenc
hightit
antimitochondri
antibodi
ama
inner
lipoyl
domain
subunit
dehydrogenas
complex
particular
compon
pyruv
dehydrogenas
complex
initi
event
trigger
autoimmun
respons
yet
identifi
hypothesi
molecular
mimicri
wide
propos
mechan
develop
autoimmun
pbc
sever
candid
includ
bacteria
virus
suggest
caus
agent
also
environment
factor
chemic
xenobiot
implic
pathogenesi
primari
biliari
cirrhosi
review
discuss
current
knowledg
immunoreact
xenobiot
modifi
pdc
peptid
antigen
addit
provid
work
hypothesi
xenobiot
modif
antigen
might
occur
ultim
lead
break
selftoler
induct
pbc
primari
biliari
cirrhosi
pbc
progress
autoimmun
liver
diseas
femal
predilect
character
immunemedi
destruct
intrahepat
small
bile
duct
lead
decreas
bile
secret
fibrosi
eventu
liver
failur
serolog
signatur
pbc
presenc
antimitochondri
antibodi
ama
highli
specif
autoantibodi
human
immunopatholog
target
ama
respons
member
famili
dehydrogenas
complex
includ
subunit
pyruv
dehydrogenas
complex
branch
chain
dehydrogenas
complex
acid
dehydrogenas
complex
dihydrolipoamid
dehydrogenas
bind
protein
ama
found
approxim
pbc
sera
sampl
ama
also
detect
bile
urin
saliva
pbc
patient
ama
titer
fluid
correl
sera
titer
target
antigen
ama
local
within
inner
mitochondri
matrix
catalyz
oxid
decarboxyl
keto
acid
substrat
enzym
common
structur
consist
ntermin
domain
contain
singl
multipl
lipoyl
group
previou
studi
demonstr
domin
epitop
recogn
ama
locat
within
lipoyl
domain
target
antigen
interestingli
five
protein
mammal
contain
lipoic
acid
four
five
autoantigen
pbc
moreov
recombin
form
mitochondri
protein
use
diagnost
posit
ama
virtual
diagnost
least
suggest
person
substanti
risk
futur
develop
pbc
evid
suggest
pbc
major
genet
basi
higher
rel
risk
nearli
autoimmun
diseas
rel
risk
famili
member
firstdegre
rel
pbc
patient
higher
gener
popul
howev
littl
associ
pbc
mhc
class
class
ii
allel
recent
group
evalu
concord
pbc
genet
defin
popul
twin
set
identifi
pair
twin
within
cohort
includ
set
monozygot
dizygot
twin
set
concord
monozygot
twin
individu
pbc
among
pair
dizygot
twin
none
found
concord
pbc
interestingli
age
onset
diseas
similar
concord
set
monozygot
pair
howev
concord
rate
pbc
ident
twin
among
highest
report
autoimmun
diseas
discord
pair
also
identifi
suggest
factor
genet
predisposit
contribut
develop
pbc
epidemiolog
studi
suggest
environment
factor
play
role
trigger
exacerb
pbc
conduct
larg
scale
epidemiolog
studi
evalu
risk
factor
comorbid
pbc
involv
control
interviewbas
studi
patient
similar
number
control
match
sex
age
race
geograph
locat
data
studi
indic
firstdegre
rel
pbc
histori
urinari
tract
infect
past
smoke
use
hormon
replac
increas
risk
pbc
frequent
use
nail
polish
slightli
increas
risk
pbc
anoth
studi
examin
preval
pbc
psc
near
superfund
site
report
signific
cluster
pbc
surround
toxic
site
autoimmun
phenomenon
character
inappropri
immun
respons
self
antigen
persist
result
tissu
damag
autoimmun
diseas
control
genet
predisposit
environment
factor
influenc
suscept
modul
reactiv
function
immun
system
mechan
respons
develop
autoimmun
diseas
remain
enigmat
howev
signific
hypothes
base
epidemiolog
scientif
fact
suggest
one
thesi
concept
molecular
mimicri
base
similar
pathogenand
host
antigenderiv
epitop
recogn
immun
system
mechan
suggest
associ
sever
system
autoimmun
diseas
includ
multipl
sclerosi
system
lupu
erythematosu
sle
rheumatoid
arthriti
howev
need
mechanist
evid
identif
similar
epitop
either
homolog
peptid
sequenc
crossrecogn
epitopespecif
lymphocyt
conform
epitop
recogn
antibodi
paradox
autoantigen
unabl
elicit
primari
immun
respons
recogn
target
effector
cell
stimul
pathogen
crossreact
epitop
break
selftoler
autoantigen
epitop
mimic
mimeotop
need
induc
activ
prolifer
rather
anergi
autoreact
cell
autoantigen
present
host
cell
certain
tissu
must
recogn
reactiv
epitopespecif
cell
caus
autoimmun
diseas
therefor
pathogen
deriv
epitop
suffici
differ
host
deriv
epitop
stimul
autoimmun
respons
although
bacteria
virus
candid
induct
autoimmun
diseas
molecular
mimicri
discuss
elsewher
also
environment
factor
xenobiot
chemic
compound
foreign
live
organ
exampl
includ
drug
pesticid
organ
molecul
potenti
modifi
host
protein
render
immunogen
number
chemic
xenobiot
associ
sever
human
autoimmun
diseas
tabl
includ
sle
factor
like
uv
light
drug
estrogen
aromat
amin
implic
develop
diseas
anoth
exampl
connect
tissu
diseas
scleroderma
develop
exposur
silica
drug
bleomycin
pentazocin
associ
xenobiot
scleroderma
interest
analog
pbc
due
increas
frequenc
coexist
autoimmun
diseas
sclerodermalik
diseas
also
caus
exposur
organ
solvent
particular
contain
vinyl
chlorid
epoxi
resin
toxic
oil
syndrom
caus
ingest
denatur
rapese
oil
spain
anoth
wellknown
exampl
connect
tissu
autoimmun
diseas
induc
chemic
exposur
chemic
link
autoimmun
includ
heavi
metal
mercuri
iodin
canavanin
halothan
halothan
hepat
xenobioticsinduc
liver
diseas
occur
suscept
individu
develop
immun
respons
trifluoroacetyl
tfa
protein
antigen
exposur
tfaconjug
self
protein
result
antibodi
respons
tfaself
protein
lipoyl
inner
lipoyl
domain
human
unlipoyl
form
recogn
antitfa
xenobiot
potenti
becom
metabol
activ
intermedi
form
coval
adduct
host
protein
problemat
issu
autoimmun
identif
etiolog
event
result
immunopatholog
event
conceiv
gener
term
genet
environment
factor
pbc
illustr
enigma
high
degre
concord
ident
twin
clinic
uniform
presenc
highli
specif
serolog
marker
antimitochondri
antibodi
ama
direct
subunit
dehydrogenas
complex
addit
mhc
class
class
iirestrict
cell
epitop
peptid
liverinfiltr
autoreact
cell
appear
local
inner
lipoyl
domain
domin
autoreact
b
cell
epitop
signatur
pbc
ama
use
probe
enabl
dissect
potenti
environment
trigger
led
proposit
incit
event
pbc
modif
major
autoantigen
xenobiot
mani
environment
chemic
metabol
primarili
liver
metabol
may
form
reactiv
metabolit
may
modifi
cellular
protein
form
neoantigen
although
clear
xenobiot
modifi
cellular
protein
initi
autoimmun
pbc
sever
mechan
propos
firstli
direct
toxic
effect
xenobiot
neoantigen
caus
abnorm
cell
death
apoptosi
necrosi
condit
favor
gener
immunogen
autoepitop
secondli
neoantigenspecif
cell
b
cell
prime
may
crossreact
less
immunogen
nativ
autoantigen
lastli
chemic
modif
nativ
cellular
protein
remov
andor
exchang
hapten
nativ
peptid
shown
chang
process
apc
lead
present
cryptic
peptid
direct
toxic
effect
xenobiot
usual
dosedepend
may
manifest
major
individu
shortli
drug
intak
result
condit
druginduc
liver
injuri
henc
rel
easili
identifi
one
exampl
halothan
hepat
trifluoroacetyl
tfa
metabolit
coval
modifi
lysin
residu
cellular
protein
induc
antibodi
respons
tfamodifi
protein
also
lipoyl
domain
human
major
autoantigen
pbc
implic
druginduc
protein
modif
also
concept
molecular
mimicri
pathogen
mechan
associ
pbc
hand
autoimmun
effect
follow
drug
toxic
may
take
prolong
timeperiod
reach
threshold
level
accompani
signific
toxic
clinic
manifest
time
period
autoimmun
reactiv
may
undergo
substanti
evolut
quantit
qualit
make
identif
caus
agent
formid
task
despit
difficulti
progress
made
use
reactiv
chemic
modifi
peptid
pbc
patient
sera
footprint
origin
neoantigen
identifi
environment
chemic
respons
gener
immunogen
neoantigen
group
longstand
interest
defin
dissect
etiolog
basi
pbc
although
identifi
major
autoantigen
pbc
event
initi
recognit
selfprotein
immunogen
still
investig
one
work
hypothes
potenti
modif
selfprotein
agent
xenobiot
may
alter
selfprotein
caus
breakdown
toler
perpetu
immun
respons
chronic
lowlevel
turnov
selfprotein
address
hypothesi
initi
synthes
peptid
contain
inner
lipoyl
domain
amino
acid
replac
lipoic
acid
moieti
panel
synthet
structur
design
mimic
xenobiot
modifi
lipoyl
hapten
quantit
reactiv
sera
pbc
patient
structur
util
microbead
elisa
assay
interestingli
antimitochondri
antibodi
ama
seroposit
patient
pbc
control
react
three
organ
modifi
autoepitop
significantli
better
nativ
domain
structur
analysi
reactiv
compound
reveal
featur
correl
autoantibodi
bind
includ
compound
halid
methyl
halid
metaor
paraposit
contain
strong
hydrogen
bond
accept
group
phenyl
ring
mani
chemic
includ
pharmaceut
household
deterg
potenti
form
halogen
deriv
metabolit
anoth
interest
find
studi
modif
lipoic
acid
moieti
trifluoroacetyl
tfa
group
result
mimic
higher
ama
reactiv
nativ
ligand
lipoic
acid
demonstr
possibl
mechan
lipoyl
group
modif
tfacontain
reagent
halothan
base
find
quantit
structureact
relationship
qsar
analysi
ama
reactiv
compound
initi
comprehens
studi
use
aa
inner
lipoyl
domain
peptid
analyz
extend
list
chemic
xenobiot
ama
recognit
use
refin
screen
strategi
employ
microarray
platform
xenobioticmodifi
peptideagaros
conjug
spot
onto
glass
slide
allow
screen
theoret
thousand
compound
small
amount
patient
sera
reagent
fig
list
includ
aliphat
aromat
compound
aliphat
compound
differ
chain
length
halogen
substitut
variou
degre
satur
aromat
compound
halogen
nitro
substitut
heterocycl
compound
see
tabl
briefli
total
potenti
xenobiot
mimic
coupl
lysin
residu
immunodomin
amino
acid
peptid
inner
lipoyl
domain
spot
onto
glass
slide
sera
pbc
n
primari
scleros
cholang
n
healthi
volunt
n
assay
ig
reactiv
xenobiot
significantli
higher
igg
igm
respect
reactiv
pbc
sera
compar
control
addit
igm
compound
reactiv
nativ
lipoyl
peptid
tabl
among
compound
cinnam
acid
deriv
carri
hydrophob
halogen
trifluoromethyl
substitut
medium
long
chain
satur
unsatur
aliphat
acid
result
let
us
hypothes
acid
moieti
attach
lysin
residu
immunodomin
peptid
must
prefer
hydrophob
charact
certain
size
success
recogn
agbind
site
ama
follow
extens
elisa
absorpt
studi
also
conclud
reactiv
acid
specif
sinc
antibodi
recogn
acid
modifi
pdc
peptid
crossreact
lipoic
acid
modifi
peptid
data
allow
refin
optim
requir
xenobiot
defin
role
alkyno
acid
character
reactiv
sera
chemic
compound
structur
similar
acid
differ
either
locat
acetylen
bond
length
carbon
chain
acidrel
xenobiot
vari
tripl
bond
locat
acid
respect
vari
chain
length
acid
respect
control
coupl
lysin
residu
pdc
inner
lipoyl
domain
peptid
immobil
agaros
bead
spot
microarray
slide
probe
sera
amaposit
patient
healthi
subject
igg
igm
reactiv
acid
tripl
bond
locat
locat
acid
significantli
lower
igg
igm
reactiv
compar
acid
fig
b
thenc
defin
role
carbon
chain
length
synthes
panel
conjug
peptid
vari
chain
length
carbon
atom
panel
sera
use
screen
ig
reactiv
modifi
peptid
significantli
higher
p
igg
reactiv
pbc
sera
control
significantli
greater
p
igm
reactiv
seen
test
compound
highest
ig
reactiv
pbc
sera
observ
conjug
react
significantli
better
p
igg
p
igm
amid
fig
c
qsar
analysi
suggest
posit
tripl
bond
posit
minimum
chain
length
seven
carbon
atom
critic
high
reactiv
among
vari
carbon
chain
length
particularli
exhibit
highest
reactiv
altogeth
data
suggest
ama
react
specif
conjug
emphas
import
role
reactiv
conjug
posit
tripl
bond
alkyno
acid
reactiv
furthermor
mediat
antibodi
sinc
absorpt
pbc
sera
increas
amount
recombin
significantli
reduc
ig
reactiv
dosedepend
manner
summari
data
indic
alkynamid
tripl
bond
conjug
posit
chain
length
carbon
atom
favor
ama
bind
optim
structur
demonstr
deriv
acid
whose
methyl
ester
rank
th
term
occup
exposur
femal
preval
due
use
cosmet
data
deriv
studi
led
assembl
seri
fact
serv
foundat
upon
formul
work
model
pathogenesi
human
pbc
fact
includ
genet
predisposit
develop
pbc
incred
focus
respons
autoantibodi
cell
respons
higher
autoreact
cell
precursor
frequenc
liver
region
lymph
node
compar
blood
pbc
higher
autoreact
cell
precursor
frequenc
liver
compar
blood
pbc
number
specif
tetram
posit
cell
highest
stage
iii
find
chemic
synthes
lipoat
mimic
form
acid
react
higher
affin
parent
lipoat
pbc
abil
xenobiot
coupl
bsa
break
toler
experiment
anim
small
bile
duct
innoc
victim
biolog
determin
target
context
also
discuss
use
recombin
antigen
studi
mani
thousand
pbc
sera
fals
posit
small
percentag
pbc
patient
ama
seroposit
chip
away
total
luminex
assay
less
overlap
syndrom
believ
either
de
novo
pbc
patient
aih
dual
diseas
frequenc
autoreact
specif
cell
approxim
ama
neg
ama
posit
pbc
patient
shimoda
person
commun
pbc
reoccur
follow
liver
transplant
convinc
evid
multilineag
antimitochondri
respons
chang
significantli
biliari
cell
also
play
role
model
believ
pbc
specif
biliari
cell
phenotyp
sinc
pbc
reoccur
transplant
rather
pbc
local
bile
duct
cell
occasion
salivari
cell
basi
uniqu
apoptot
properti
presenc
poli
ig
intens
mucos
respons
bile
duct
epitheli
cell
suscept
gene
pbc
remain
undefin
like
multigen
herein
chosen
focu
environment
arm
hypothesi
thu
postul
break
toler
take
place
outlin
fig
model
requir
presenc
everi
one
event
howev
common
denomin
immun
respons
lipoyl
contain
mitochondri
antigen
mous
model
predict
develop
pbc
similar
mechan
name
multilineag
loss
toler
promiscu
facilit
host
decad
correl
ama
titer
diseas
sever
ama
often
consid
epiphenomena
work
past
two
decad
argu
otherwis
role
mitochondri
respons
must
view
broad
context
multilineag
respons
model
requir
initi
loss
toler
initi
event
environment
trigger
may
vari
individu
final
immun
pathway
immunopatholog
previous
state
proposit
incit
event
pbc
modif
major
autoantigen
xenobiot
conjug
six
distinct
modif
involv
xenobiot
conjug
envis
xenobiot
modif
lipoyl
moieti
ie
ii
modif
wherein
xenobiot
replac
lipoic
acid
ie
x
iii
xenobiot
modif
proxim
lipoic
acid
ie
la
iv
concomit
xenobiot
modif
lipoic
acid
ie
la
v
concomit
xenobiot
modif
replac
lipoic
acid
ie
x
fig
vi
carrier
protein
cp
modif
xenobiot
ie
cpx
fig
studi
detail
herein
build
detail
qsar
work
led
identif
sever
chemic
mimic
ie
peptidesmal
molecul
conjug
react
pbc
sera
well
better
nativ
autoantigen
design
differenti
variou
scenario
henc
believ
caus
pbc
autoimmun
reactiv
selfprotein
subsequ
patholog
suscept
biliari
epitheli
cell
schemat
microarray
base
assay
util
xenobiot
modifi
peptideagaros
conjug
igm
reactiv
noctynamideor
peptid
pbc
sera
pbc
patient
sera
c
healthi
control
sera
b
analyz
microarray
igm
reactiv
peptid
modifi
noctyno
b
acid
c
reactiv
individu
sampl
mean
reactiv
shown
asterisk
indic
signific
differ
p
unpair
test
igm
reactiv
pbc
control
sera
propos
model
break
toler
pbc
schemat
possibl
xenobiot
modif
carrier
protein
xenobiot
may
alter
either
replac
lipoic
acid
moieti
chemic
modifi
lipoic
acid
andor
modifi
proxim
lipoyl
domain
creat
immunolog
mimic
addit
xenobiot
might
abl
modifi
carrier
protein
albumin
elicit
immun
respons
xenobiot
crossreact
nativ
b
la
lipoic
acid
x
xenobiot
lip
lipoyl
domain
toxic
oil
syndrom
sclerodermalik
connect
tissu
diseas
